Malignant Melanoma
6 drugs945 FAERS reportsMedDRA PT
GET
/api/v1/reaction/malignant-melanomaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D008545
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Drugs reporting Malignant Melanoma (6)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Titanium Dioxide123.4%
- 2Oxybenzone213.0%
- 3Homosalate293.0%
- 4Vardenafil172.5%
- 5Dabrafenib4352.1%
- 6Trametinib4311.8%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Metastatic Malignant Melanoma2 shared · 0.33
- Sunburn3 shared · 0.25
- Product Expiration Date Issue2 shared · 0.25
- Basal Cell Carcinoma2 shared · 0.22
- Skin Cancer2 shared · 0.22
- Circumstance Or Information Capable Of Leading To Medication Error2 shared · 0.10
- Metastases To Central Nervous System2 shared · 0.10
- Blister2 shared · 0.05
- Application Site Erythema2 shared · 0.05
- Skin Exfoliation2 shared · 0.04
Literature
Recent PubMed references pinned to Melanoma as a MeSH major topic. About the reaction term itself — not about any specific drug.
- [Single-cell transcriptome analysis reveals heterogeneous features of cancer-associated fibroblasts in acral melanoma].Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology · 2026 · Du Z, Rao W, Wang Y, et al.PMID 42206704
- Temporal trends in the probability of melanoma diagnosis in four Nordic countries, 1973-1999.Cancer causes & control : CCC · 2026 · Moro O, Schopf TR, Veierød MB, et al.PMID 42201376DOI 10.1007/s10552-026-02181-w
- The immune landscape of melanoma microenvironmental crosstalk.Frontiers in immunology · 2026 · Yang Q, Yang Q, Xu B, et al.PMID 42199415DOI 10.3389/fimmu.2026.1847963
- Dynamic Time-Resolved Remodeling of the Immune Microenvironment After Resistance to BRAF/MEK Inhibitors in Melanoma: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies.International journal of molecular sciences · 2026 · Meng W, Liu Y, Zhang H, et al.PMID 42196460DOI 10.3390/ijms27104484
- Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma.International journal of molecular sciences · 2026 · Bătrîna O, Negrea-Ghiulai R, Suciu L, et al.PMID 42196415DOI 10.3390/ijms27104423
- Circulating Cytokines in Melanoma Prognosis: Current Evidence and Future Perspectives.Medicina (Kaunas, Lithuania) · 2026 · Lapeikis I, Urbonas VPMID 42195213DOI 10.3390/medicina62050960
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.